Stem cell clones could yield new drug treatment for deadly blood disease
FA is a hereditary blood disorder that leads to bone marrow failure (FA-BMF) and cancer
Author
A Question of Trust
Though buying medicines online has become a convenience for the patients, the reliability and the authenticity of such online…
Global Type I diabetes treatment market value doubling to $13.6 billion by 2023: GlobalData
Across the eight major markets of the US, France, Germany, Italy, Spain, UK, Japan and Canada, growth will be driven primarily by…
Targeted therapies offer novel treatment modalities for breast cancer: Frost & Sullivan
The use of combination targeted therapies will improve progression-free disease as well as survival rates
Reorienting the innovation management process
In the search for growth, pharmaceutical companies often face harsh reality when new OTC launches flop because they did not match…
In Your Genes
Genetic testing is gaining ground in India with a spurt in the number of companies offering personalised tests. And while most of…
US FDA, DCG(I) explore more ways to work together
Willing to collaborate with Indian regulators, other stakeholders: US FDA
SC stays Delhi HC order against Glenmark
Company can make, sell its brands of MSD's diabetes products till April 28
End of Wockhardt’s Chikalthana USFDA woes?
No major findings from recent USFDA inspection, after 2013 import alert on the company's Aurangabad-based Waluj and Chikalthana…
Sun Pharma closes merger deal with Ranbaxy
The combined entity’s manufacturing footprint covers five continents with products sold in over 150 nations